banner image

Investor FAQ

Investor FAQ

Show All
When and where was Keros Therapeutics founded?
Keros was incorporated in the state of Delaware in December 2015 and commenced operations in April 2016.
Where is Keros Therapeutics’ corporate headquarters?
Keros’ headquarters are located at 99 Hayden Avenue, Suite 120, Building E, Lexington, MA 02421. The main office phone number is +1 617 314 6297.
On which exchange is Keros Therapeutics listed, what is the ticker symbol and when did it go public?
Keros’ common stock is traded on the Nasdaq Global Market under the symbol KROS. Our initial public offering occurred on April 8, 2020.
Who are Keros’ independent auditors and legal counsel?

Our independent auditor is:
Deloitte & Touche LLP
200 Berkeley St.
Boston, MA 02116

Our legal counsel is:
Cooley LLP
500 Boylston Street
Boston, Massachusetts 02116
+1 617 937 2300

When does Keros' fiscal year end?

Our fiscal year ends on December 31.

Who is Keros' transfer agent?

Computershare Trust Company, N.A.
www.computershare.com/investor
U.S. Phone: +1 877 373 6374
International Phone: +1 781 575 2879

Address for first class, registered, and certified mail:
Computershare Investor Services
P.O. Box 505000
Louisville, KY, 40233-5000 USA

Address for overnight delivery:
Computershare Investor Services
462 South 4th Street, Suite 1600
Louisville, KY, 40202 USA

What is Keros’ CUSIP number?

The CUSIP number for Keros’ common stock is 492327 101.

How can I replace my lost stock certificates?

If you have misplaced your stock certificates, please contact Keros’ transfer agent, Computershare.

Computershare Trust Company, Inc.
www.computershare.com
US Phone: +1 877 373 6374
International Phone: +1 781 575 2879

There may be a fee involved for replacing lost stock certificates.

How can I purchase shares?

Shares can be purchased through any registered broker.

Does Keros pay dividends?

Keros does not expect to declare or pay any cash or other dividends on our common stock.

Follicular_Lymphoma_in_Bone_Marrow image